GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • *Alexion offers $225.92 per Synageva share in cash and stock. May 6- Drugmaker Alexion Pharmaceuticals Inc agreed to buy Synageva BioPharma Corp for $8.4 billion at a hefty premium to expand in the lucrative market for drugs that treat rare diseases. The drug, whose marketing application is being reviewed in the United States and Europe, treats a rare and...

  • It also scaled back plans to return 4 billion pounds of cash flowing from a $20 billion- plus asset swap with Novartis to investors, opting instead to pay a 1 billion special dividend. Chief Executive Andrew Witty is under pressure to demonstrate that the Novartis deal can revive GSK's fortunes by focusing it on consumer health and vaccines, following a slide in...

  • GlaxoSmithKline opts to hold on to HIV business Wednesday, 6 May 2015 | 8:14 AM ET

    LONDON— British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis. Those deals included GSK's sale of its cancer-drug business to Novartis in a swap for the Swiss company's vaccines business and cash. GSK said it would reduce a planned...

  • Two pharma giants merge in $8.4B deal Wednesday, 6 May 2015 | 8:01 AM ET
    Pharmaceuticals

    Alexion said it would buy Synageva for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease.

  • Alexion Pharma to buy Synageva BioPharma for $8.4 bln Wednesday, 6 May 2015 | 6:54 AM ET

    May 6- Drugmaker Alexion Pharmaceuticals Inc said it would buy Synageva BioPharma Corp for $8.4 billion to gain access to its experimental early-stage treatment for a rare metabolic disease. Alexion's cash-and-stock offer values Synageva at $225.92 per share, representing a premium of 135.7 percent to the stock's close on Tuesday. The deal is expected to...

  • PHILADELPHIA— A pediatrician researching tuberculosis, HIV and other infectious diseases was strangled by an exterminator after she questioned his work and was then tied up with equestrian gear and set on fire, a prosecutor said Wednesday in opening statements at his murder trial. Melissa Ketunuti, 35, had graduated from Stanford University medical school,...

  • *More than 24 mln birds affected by flu virus- USDA. CHICAGO, May 5- The U.S. government approved the use of an additional $330 million in emergency funds to help contain the worst avian influenza outbreak in U.S. history, as infected bird cases soared and hundreds of Minnesota poultry workers learned they would lose their jobs. Agriculture Secretary Tom Vilsack's...

  • FRANKFURT, May 5- German genetic tests maker Qiagen NV reported a 4 percent fall in adjusted quarterly net profit as U.S. sales of its human papillomavirus test declined and the dollar strengthened, eroding the value of revenues in Europe. Qiagen said on Tuesday that U.S. sales of its HPV test, previously one of its main profit drivers, fell 54 percent due to lower...

  • IBM's Watson to guide cancer therapies at 14 centers Tuesday, 5 May 2015 | 2:00 PM ET

    NEW YORK, May 5- Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp's Watson computer system to choose therapies based on a tumor's genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients. Faced with such a data deluge, "the solution is going to be...

  • HARTFORD, Conn.— The health insurer Aetna is ending most coverage of hysterectomies performed with a once-popular device that has drawn warnings from federal regulators over a risk for spreading cancer. Aetna Inc. will make exceptions for pre-menopausal women who want to maintain their fertility and for whom another treatment would not be effective.

  • May 4- Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco. Corbus, a tiny biopharmaceutical company, received $5 million from the Cystic Fibrosis Foundation last month to develop...

  • U.S. top court rejects hepatitis B drug patent case Monday, 4 May 2015 | 9:40 AM ET

    WASHINGTON, May 4- The U.S. Supreme Court on Monday brought to an end Bristol-Myers Squibb Co's attempt to revive patent protection for its Baraclude treatment for hepatitis B. The high court declined to hear Bristol-Myers' challenge to an appeals court ruling in favor of generic rival Teva Pharmaceutical Industries Ltd, which had successfully challenged the...

  • WICHITA, Kan.— Farmers and other agriculture industry leaders will fan out across Kansas in the coming days to examine the extent of damage to winter wheat from drought, disease and winterkill. Reports of a heavy infestation of the disease have surfaced in southeast Kansas near Altamont and more moderate cases have also surfaced in Labette around Labette...

  • DES MOINES, Iowa— It's been five months since the H5N2 bird flu virus was discovered in the United States, and producers have lost 21 million birds in the Midwest alone. Scientists at the U.S. Department of Agriculture, the Centers for Disease Control and Prevention and other federal agencies are puzzled by the H5N2 virus' spread— even amid heightened biosecurity...

  • CHICAGO, May 1- Iowa Governor Terry Branstad declared a state of emergency on Friday due to a rapidly expanding avian flu outbreak, soon after state agriculture officials announced four new poultry farms had initially tested positive for the virus. Iowa, the top egg-producing state in the United States, is the third state to declare a state of emergency because...

  • CHICAGO, May 1- Hog farmers are six times more likely than the general population to carry an infectious bacteria that can cause skin and respiratory problems and resists treatment from multiple drugs, according to a new U.S. research study. The study, published this week in the online journal Clinical Infectious Diseases, is the largest-ever examination of...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. The egg farm's owner, Rembrandt Foods, one of the top U.S. egg producers, confirmed the outbreak but disputed the number of birds affected.

  • Tandem Diabetes reports 1Q loss Thursday, 30 Apr 2015 | 7:09 PM ET

    SAN DIEGO _ Tandem Diabetes Care Inc. on Thursday reported a loss of $21.2 million in its first quarter. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • April 30- The U.S. Food and Drug Administration on Thursday approved The Medicines Co's dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The approval comes at a time Medicines Co is facing a drop in sales of its lead product, Angiomax anticoagulant injection, which accounted for over 80...

  • CHICAGO, April 30- The highly pathogenic H5 avian flu turned up in initial tests at five more farms in Iowa, including a commercial egg operation housing up to 5.5 million birds, Iowa's agriculture department said on Thursday. Avian flu was "probable" at four other commercial farms in Buena Vista, Sioux and Clay counties, the Iowa Department of Agriculture and Land...